✅Pro: Lowers long-term costs ✅Pro: Creates competitive advantage Thoratec ❌Con: Raises cost for consumers Extra words: 🌎ID&E: Opportunity to design for inclusion 🌎 ID&E:Impacts affordability for underserved populations TAVR- AR ✅Pro: Encourages efficiency ✅Pro: Improves patient outcomes “Case Study Mentioned” 🌎ID&E: May reduce equitable access if costs rise ❌Con: Can limit innovation (if monopolized) “Innovation” Edwards Lifesciences ❌Con: Stifles smaller competitors 🌎ID&E: Increases access to life-saving devices ✅Pro: Promotes faster development 🌎ID&E: Risk of bias in technology adoption HeartWare ❌Con: Reduces competition ❌Con: Potential job loss in smaller firms 🌎ID&E: Could create global disparities JenaValve ❌Con: Risk of market monopoly ❌Con: Antitrust challenges 🌎ID&E: Regulatory oversight protects fairness ✅Pro: Expands treatment options ✅Pro: Drives innovation “Antitrust” ✅Pro: Lowers long-term costs ✅Pro: Creates competitive advantage Thoratec ❌Con: Raises cost for consumers Extra words: 🌎ID&E: Opportunity to design for inclusion 🌎 ID&E:Impacts affordability for underserved populations TAVR- AR ✅Pro: Encourages efficiency ✅Pro: Improves patient outcomes “Case Study Mentioned” 🌎ID&E: May reduce equitable access if costs rise ❌Con: Can limit innovation (if monopolized) “Innovation” Edwards Lifesciences ❌Con: Stifles smaller competitors 🌎ID&E: Increases access to life-saving devices ✅Pro: Promotes faster development 🌎ID&E: Risk of bias in technology adoption HeartWare ❌Con: Reduces competition ❌Con: Potential job loss in smaller firms 🌎ID&E: Could create global disparities JenaValve ❌Con: Risk of market monopoly ❌Con: Antitrust challenges 🌎ID&E: Regulatory oversight protects fairness ✅Pro: Expands treatment options ✅Pro: Drives innovation “Antitrust”
(Print)
✅Pro: Lowers long-term costs
✅Pro: Creates competitive advantage
Thoratec
❌Con: Raises cost for consumers
Extra words:
🌎ID&E: Opportunity to design for inclusion
🌎ID&E:Impacts affordability for underserved populations
TAVR-AR
✅Pro: Encourages efficiency
✅Pro: Improves patient outcomes
“Case Study Mentioned”
🌎ID&E: May reduce equitable access if costs rise
❌Con: Can limit innovation (if monopolized)
“Innovation”
Edwards Lifesciences
❌Con: Stifles smaller competitors
🌎ID&E: Increases access to life-saving devices
✅Pro: Promotes faster development
🌎ID&E: Risk of bias in technology adoption
HeartWare
❌Con: Reduces competition
❌Con: Potential job loss in smaller firms
🌎ID&E: Could create global disparities
JenaValve
❌Con: Risk of market monopoly
❌Con: Antitrust challenges
🌎ID&E: Regulatory oversight protects fairness
✅Pro: Expands treatment options
✅Pro: Drives innovation
“Antitrust”
